Literature DB >> 3530187

Immunohistochemical studies of rhabdomyosarcoma.

R Scupham, E F Gilbert, J Wilde, T A Wiedrich.   

Abstract

We performed immunoperoxidase studies in 29 cases of rhabdomyosarcoma from the Intergroup Rhabdomyosarcoma Study I using antisera against actin, myosin, myoglobin, alpha-actinin, and tropomyosin. Although each of these antisera reacted with some of the tumors, none reacted with all of the tumors, and some tumors showed no reactivity. Antimyosin reacted with more tumors than any of the others, while antiactin and antimyoglobin were about equally sensitive. Antitropomyosin and anti-alpha-actinin reacted with few of the tumors. The better-differentiated tumors were more likely to react compared with the poorly differentiated tumors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530187

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.

Authors:  R A Schmidt; R Cone; J E Haas; A M Gown
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

2.  Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.

Authors:  G Tallini; D M Parham; P Dias; C Cordon-Cardo; P J Houghton; J Rosai
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

3.  Rhabdomyosarcoma in the region of the sella turcica.

Authors:  S Jalalah; K Kovacs; E Horvath; W Couldwell; M H Weiss; C Ezrin
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

4.  Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.

Authors:  N P Wang; J Marx; M A McNutt; J C Rutledge; A M Gown
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.